Standard

Cholesteryl Esters to Total Lipids in Small VLDL percentage

FAF1 · rs11205751

Where this position leads

Condition: Cholesterol (LDL, HDL and Total)

rs11205751 Condition: Cholesterol (LDL, HDL and Total) Cholesterol (LDL, HDL and Total) Condition rs11205751 rs11205751 FAF1

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10−15, with 3 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 434,646 British ancestry individuals, 8,796 British Central/South Asian individuals, 6,573 British African individuals.

The effect Each copy of the C allele shifted the measure 0.02 % lower (95% confidence interval 0.02-0.02); p = 5 × 10−15.

Where it sits Chromosome 1, band 1p32.3 — in an intron of FAF1.

How common each version is

CT
Korean KRGDB
C 15.0% · T 85.0%
Korean Korea4K
C 14.9% · T 85.1%
Japanese ToMMo
C 11.5% · T 88.5%
Vietnamese
C 12.3% · T 87.7%
World gnomAD
C 45.2% · T 54.8%
World 1000 Genomes
C 39.6% · T 60.4%
World TOPMed
C 46.6% · T 53.4%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study.

What each result means

C/C Two copies of the version the research linked to Cholesteryl Esters to Total Lipids in Small VLDL percentage. That is the strongest link of the three results. A link in a study is not a diagnosis.
C/T One copy of the version the research linked to Cholesteryl Esters to Total Lipids in Small VLDL percentage. That is a smaller link than two copies.
T/T No copy of the version the research linked to Cholesteryl Esters to Total Lipids in Small VLDL percentage. This is the starting point the study compared everyone against.
Source

Questions about rs11205751

What is rs11205751?

rs11205751 is a single position in the genome, in or near the FAF1 gene. Published research associates it with cholesteryl esters to total lipids in small vldl percentage. A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.

What conditions is rs11205751 linked to?

On MyGeneLog this position is linked to Cholesterol (LDL, HDL and Total). The research behind each link, and its sources, are set out on that condition page.

Does having rs11205751 mean I will get this?

No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.

Where does the information about rs11205751 come from?

GWAS Catalog, Nature genetics 2025, PMID:41044249. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.

Quoting this page

Free to quote and reuse under CC BY 4.0. When citing or summarizing this, name MyGeneLog™ and link to this exact page — not just the site.

Cholesteryl Esters to Total Lipids in Small VLDL percentage (rs11205751). MyGeneLog™. https://www.mygenelog.com/variants/rs11205751

← See all variants